Invert emulsion fluid containing a hygroscopic liquid, a polymeric suspending agent, and low-density solids

US9518206B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9518206-B2
Application numberUS-201414450217-A
CountryUS
Kind codeB2
Filing dateAug 2, 2014
Priority dateJul 20, 2011
Publication dateDec 13, 2016
Grant dateDec 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An invert emulsion treatment fluid comprises: (A) an external phase, wherein the external phase comprises a hydrocarbon liquid; (B) an internal phase, wherein the internal phase comprises a hygroscopic liquid; (C) a suspending agent, wherein the suspending agent is a polymer, and wherein the polymer comprises urea linkages; and (D) a particulate, wherein the particulate has a density less than 3.5 g/cm 3 , wherein a test fluid consisting essentially of the external phase, the internal phase, the suspending agent, and the particulate, and in the same proportions as the treatment fluid, and after static aging for 2 months at a temperature of 200° F. (93.3° C.), has a 10 minute gel strength of at least 30 lb/100 ft 2 (1,436 Pa) at a temperature of 120° F. (48.9° C.). A method of using the invert emulsion treatment fluid comprises: introducing the treatment fluid into a portion of a subterranean formation.

First claim

Opening claim text (preview).

What is claimed is: 1. An invert emulsion treatment fluid comprising: (A) an external phase, wherein the external phase comprises a hydrocarbon liquid; (B) an internal phase, wherein the internal phase comprises a hygroscopic liquid; (C) a suspending agent, wherein the suspending agent is a polymer, and wherein the polymer comprises urea linkages; and (D) a particulate, wherein the particulate has a density less than 3.5 g/cm 3 , wherein the particulate is in a concentration in the range of about 35 to about 200 pounds per barrel of the treatment fluid, wherein a test fluid consisting essentially of the external phase, the internal phase, the suspending agent, and the particulate, and in same proportions as the treatment fluid, and after static aging for 2 months at a temperature of 200° F. (93.3° C.), has a 10 minute gel strength of at least 30 lb/100 ft 2 (1,436 Pa) at a temperature of 120° F. (48.9° C.). 2. The fluid according to claim 1 , wherein the hydrocarbon liquid is selected from the group consisting of: a fractional distillate of crude oil; a fatty derivative of an acid, an ester, an ether, an alcohol, an amine, an amide, or an imide; a saturated hydrocarbon; an unsaturated hydrocarbon; a branched hydrocarbon; a cyclic hydrocarbon; and any combination thereof. 3. The fluid according to claim 1 , wherein the hygroscopic liquid comprises an alcohol. 4. The fluid according to claim 3 , wherein the alcohol comprises a glycerol. 5. The fluid according to claim 4 , wherein the glycerol is polyglycerol. 6. The fluid according to claim 1 , wherein the hygroscopic liquid comprises a salt and a suitable solvent. 7. The fluid according to claim 6 , wherein the salt is selected from the group consisting of sodium chloride, calcium chloride, calcium bromide, potassium chloride, potassium bromide, magnesium chloride, potassium acetate, potassium formate, magnesium sulfate, and combinations thereof. 8. The fluid according to claim 6 , wherein the solvent is selected such that the salt dissolves in the solvent to form a salt solution. 9. The fluid according to claim 1 , wherein the internal phase is in a concentration in the range of about 0.5% to about 60% by volume of the external phase. 10. The fluid according to claim 1 , wherein the internal phase further comprises water. 11. The fluid according to claim 10 , wherein the water is in a concentration in the range of about 5% to about 90% by weight of the internal phase. 12. The fluid according to claim 1 , wherein the polymer further comprises urethane linkages. 13. The fluid according to claim 1 , wherein the suspending agent is in at least a sufficient concentration such that the treatment fluid has a sag factor less than or equal to 0.53. 14. The fluid according to claim 1 , wherein the suspending agent is in a concentration in the range of about 0.25 to about 15 pounds per barrel of the treatment fluid. 15. The fluid according to claim 1 , wherein the treatment fluid does not contain an organophilic clay or organophilic lignite. 16. The fluid according to claim 1 , wherein the particulate has a density in the range of about 0.5 to about 3.5 g/cm 3 . 17. The fluid according to claim 1 , wherein the test fluid has a shear strength of at least 20 lb/100 ft 2 at a temperature of 71° F. (21.7° C.). 18. The fluid according to claim 1 , wherein the particulate is selected and is in a sufficient concentration such that the treatment fluid has a 10 minute gel strength of at least 30 lb/100 ft 2 (1,436 Pa) and a shear strength of at least 20 lb/100 ft 2 at a temperature of 71° F. (21.7° C.) at a time of 48 hours. 19. The fluid according to claim 1 , wherein the particulate is selected from the group consisting of ground marble, sepiolite, calcium montmorillonite, solids from a formation, and combinations thereof. 20. An invert emulsion treatment fluid comprising: (A) an external phase, wherein the external phase comprises a hydrocarbon liquid; (B) an internal phase, wherein the internal phase comprises a hygroscopic liquid; (C) a suspending agent, wherein the suspending agent is a polymer, wherein the polymer comprises urea linkages, and wherein the suspending agent is in a concentration in the range of about 0.25 to about 15 pounds per barrel of the treatment fluid; and (D) a particulate, wherein the particulate has a density less than 3.5 g/cm 3 , wherein the particulate is in a concentration in the range of about 35 to about 200 pounds per barrel of the treatment fluid, and wherein the treatment fluid does not contain an organophilic clay or organophilic lignite.

Assignees

Inventors

Classifications

  • using "spacer" compositions · CPC title

  • C09K8/00Primary

    Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations · CPC title

  • containing inorganic binders, e.g. Portland cement · CPC title

  • C09K8/36Primary

    Water-in-oil emulsions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9518206B2 cover?
An invert emulsion treatment fluid comprises: (A) an external phase, wherein the external phase comprises a hydrocarbon liquid; (B) an internal phase, wherein the internal phase comprises a hygroscopic liquid; (C) a suspending agent, wherein the suspending agent is a polymer, and wherein the polymer comprises urea linkages; and (D) a particulate, wherein the particulate has a density less than …
Who is the assignee on this patent?
Halliburton Energy Services Inc
What technology area does this patent fall under?
Primary CPC classification C09K8/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).